Blood culture utilization and impact of stewardship practices during a national blood culture bottle shortage at a cancer center
Authors:
Open Access
- 14 January 2026
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 64 (1) , e0116025
Abstract
Formulating safe and effective diagnostic stewardship guidance for blood cultures in immunocompromised patients is challenging due to limited data and high risk of infectious complications. A 2024 global shortage in blood culture bottles (BD Diagnostics) necessitated the implementation of blood culture stewardship, including at our tertiary care cancer center. This was a retrospective pre-post intervention study of the effects of diagnostic stewardship at a stand-alone cancer center during a 5-month period of the 2024 blood culture bottle shortage compared to the same 5-month unaffected period in 2023. Interventions included discontinuation of an ordering set for persistent fever, modification of an ordering set for new fever to recommend two sets of blood cultures for initial workup, and issuing revised blood culture ordering guidance to providers, phlebotomists, and nurses with repeated educational efforts. Stewardship interventions led to decreased blood culture utilization by 36.3% (from 14,021 to 8,932), while the number of patients tested remained similar. Greatest reductions in utilization occurred in inpatient encounters and with follow-up blood cultures. There was a trend toward increasing blood culture positivity following intervention, excluding potential contaminants (7.1% vs 7.6%, P = 0.08). The frequency of sepsis-coded encounters and 30-day mortality rate were similar between the two time periods. No adverse outcomes related to blood culture stewardship were reported. A significant reduction in blood culture utilization is achievable in a high-complexity cancer patient population without negative clinical impact through limiting the number of initial blood cultures and eliminating pre-emptive ordering of blood culture orders for persistent fever. IMPORTANCE: Cancer and transplant patient populations are frequently excluded from experimental studies on decreasing blood culture utilization, but a recent global supply shortage in blood culture bottles provided a valuable opportunity to evaluate the effects of stewardship interventions on a large scale. This study, centered on a high-complexity cancer patient population, found that a significant 36.3% reduction in blood culture utilization was achievable, safe, and effective through multidisciplinary diagnostic stewardship efforts.Keywords
This publication has 22 references indexed in Scilit:
- Impact of BD BACTEC blood culture bottle shortage on performance metrics: An interrupted time-series analysis at a Japanese university-affiliated hospitalJournal of Infection and Chemotherapy, 2025
- Blood culture bottle shortage mitigation efforts: analysis of impact on ordering and patient impactAntimicrobial Stewardship & Healthcare Epidemiology, 2025
- Blood Culture Use in Medical and Surgical Intensive Care Units and WardsJAMA Network Open, 2025
- Rapid implementation of a clinical decision-support workflow during the national blood culture bottle shortageInfection Prevention in Practice, 2024
- Current microbiological testing approaches and documented infections at febrile neutropenia onset in patients with hematologic malignanciesInternational Journal of Infectious Diseases, 2024
- Does This Patient Need Blood Cultures? A Scoping Review of Indications for Blood Cultures in Adult Nonneutropenic InpatientsClinical Infectious Diseases, 2020
- Clinical significance of repeat blood cultures during febrile neutropenia in adult acute myeloid leukaemia patients undergoing intensive chemotherapyInfectious Diseases, 2017
- Does This Adult Patient With Suspected Bacteremia Require Blood Cultures?JAMA, 2012
- Optimal Testing Parameters for Blood CulturesClinical Infectious Diseases, 2004
- Utility of obtaining blood cultures in febrile neutropenic patients undergoing bone marrow transplantationBone Marrow Transplantation, 2000